Reproductive and hormonal factors and mortality among women with colorectal cancer in the NIH-AARP Diet and Health Study

British Journal of Cancer

Volumn 113, Issue 3, 2015, Pages 562-568

  Arem, H ^a   Park, Y ^b   Felix, A S ^a   Zervoudakis, A ^c   Brinton, L A ^a   Matthews, C E ^a   Gunter, M J ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WINTHROP UNIVERSITY HOSPITAL   (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT; SEX HORMONE;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER STAGING; COLORECTAL CANCER; DIET; DRUG USE; FEMALE; FOLLOW UP; HEALTH STATUS; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; MIDDLE AGED; ORAL CONTRACEPTIVE USE; PARITY; POSTMENOPAUSE; PRIORITY JOURNAL; REPRODUCTION; AGE; BLOOD; COHORT ANALYSIS; COLORECTAL NEOPLASMS; DRUG EFFECTS; ESTROGEN THERAPY; MORTALITY; PHYSIOLOGY; PREGNANCY; REPRODUCTIVE HISTORY; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; AGED; COHORT STUDIES; COLORECTAL NEOPLASMS; CONTRACEPTIVES, ORAL, HORMONAL; DIET; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; GONADAL STEROID HORMONES; HUMANS; MENARCHE; MIDDLE AGED; PARITY; POSTMENOPAUSE; PREGNANCY; REPRODUCTIVE HISTORY;

EID: 84938414760     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.224     Document Type: Article

References (25)

1. American Cancer Society (2014) Cancer Facts and Figures 2014. American Cancer Society: Atlanta, GA, USA.
2. Barzi A, Lenz AM, Labonte MJ, Lenz H-J (2013) Molecular pathways: estrogen pathway in colorectal cancer. Clin Cancer Res 19(21): 5842-5848.
3. Brenner H, Hoffmeister M, Arndt V, Haug U (2007) Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer 96(5): 828-831.
4. Chan JA, Meyerhardt JA, Chan AT, Giovannucci EL, Colditz GA, Fuchs CS (2006) Hormone replacement therapy and survival after colorectal cancer diagnosis. J Clin Oncol 24(36): 5680-5686.
5. Foley EF, Jazaeri AA, Shupnik MA, Jazaeri O, Rice LW (2000) Selective loss of estrogen receptor b in malignant human colon. Cancer Res 60(2): 245-248.
6. Fritz AG (2000) International Classification of Diseases for Oncology: ICD-O. World Health Organization.
7. Grodstein F, Newcomb PA, Stampfer MJ (1999) Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 106(5): 574-582.
8. Hermansen SW, Leitzmann MF, Schatzkin A (2009) The impact on National Death Index ascertainment of limiting submissions to Social Security Administration Death Master File matches in epidemiologic studies of mortality. Am J Epidemiol 169: 901-908.
9. Jacobsen BK, Vollset SE, Kvåle G (1995) Do reproductive factors influence colorectal cancer survival? J Clin Epidemiol 48(9): 1119-1122.
10. Lin J, Zhang SM, Cook NR, Manson JE, Buring JE, Lee I-M (2007) Oral contraceptives, reproductive factors, and risk of colorectal cancer among women in a prospective cohort study. Am J Epidemiol 165(7): 794-801.
11. Lindheim SR, Duffy DM, Kojima T, Vijod MA, Stanczyk FZ, Lobo R (1994) The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women. Fertil Steril 62(6): 1176-1180.
12. Mandelson MT, Miglioretti D, Newcomb PA, Harrison R, Potter JD (2003) Hormone replacement therapy in relation to survival in women diagnosed with colon cancer. Cancer Causes Control 14(10): 979-984.
13. Martinez ME, Grodstein F, Giovannucci E, Colditz GA, Speizer FE, Hennekens C, Rosner B, Willett WC, Stampfer MJ (1997) A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 6(1): 1-5.
14. McMichael AJ, Potter JD (1980) Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst 65(6): 1201-1207.
15. Michaud D, Midthune D, Hermansen S, Leitzmann M, Harlan L, Kipnis V, Schatzkin A (2005) Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Registry Manag 32(2): 70-75.
16. Newcomb PA, Chia VM, Hampton JM, Doria-Rose VP, Dietz AT (2009) Hormone therapy in relation to survival from large bowel cancer. Cancer Causes Control 20(4): 409-416.
17. Persson I, Yuen J, Bergkvist L, Schairer C (1996) Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy-long-term follow-up of a Swedish cohort. Int J Cancer 67(3): 327-332.
18. Ritenbaugh C, Stanford JL, Wu L, Shikany JM, Schoen RE, Stefanick ML, Taylor V, Garland C, Frank G, Lane D (2008) Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial. Cancer Epidemiol Biomarkers Prev 17(10): 2609-2618.
19. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288(3): 321-333.
20. Sato R, Suzuki T, Katayose Y, Miura K, Shiiba K, Tateno H, Miki Y, Akahira J, Kamogawa Y, Nagasaki S (2009) Steroid sulfatase and estrogen sulfotransferase in colon carcinoma: regulators of intratumoral estrogen concentrations and potent prognostic factors. Cancer Res 69(3): 914-922.
21. Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, Hurwitz PE, Coyle L, Schussler N, Michaud DS (2001) Design and Serendipity in Establishing a Large Cohort with Wide Dietary Intake Distributions The National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 154(12): 1119-1125.
22. Singh S, Paraskeva C, Gallimore PH, Sheppard MC, Langman MJ (1994) Differential growth response to oestrogen of premalignant and malignant colonic cell lines. Anticancer Res 14(3A): 1037-1041.
23. Slattery ML, Anderson K, Samowitz W, Edwards SL, Curtin K, Caan B, Potter JD (1999) Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA). Cancer Causes Control 10(5): 467-473.
24. Tamakoshi K, Wakai K, Kojima M, Watanabe Y, Hayakawa N, Toyoshima H, Yatsuya H, Kondo T, Tokudome S, Hashimoto S (2004) A prospective study of reproductive and menstrual factors and colon cancer risk in Japanese women: findings from the JACC study. Cancer Sci 95(7): 602-607.
25. Zervoudakis A, Strickler HD, Park Y, Xue X, Hollenbeck A, Schatzkin A, Gunter MJ (2011) Reproductive history and risk of colorectal cancer in postmenopausal women. J Natl Cancer Inst 103(10): 826-834.